Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review

Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review

In this review, we examine the impact of the Inflation Reduction Act (IRA) of 2022 on pharmaceutical drugs in the United States, drawing on a diverse range of sources to understand the perceptions of multiple stakeholders and professionals. Findings suggest that the Act, while aiming to control pric...

Full description

Bibliographic Details
Main Authors: Cristian Lieneck, Matthew McLauchlan, Valerie Adachi, Roger Billings
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmacy
Subjects:
Inflation Reduction Act
prescription drugs
pharmaceuticals
drug prices
inflation
Online Access:https://www.mdpi.com/2226-4787/11/6/187

Internet

https://www.mdpi.com/2226-4787/11/6/187

Similar Items